Harvard Medical School

Lack of specialists doom rural sick patients | 12/4/2019

… that people in rural areas have less access to specialist physicians like cardiologists and endocrinologists.” Johnston and his coauthors, Hefei Wen, Ph.D., assistant professor in the division of health policy and insurance research at Harvard Medical School and the Harvard Pilgrim Health Care Institute, and Karen E. Joynt Maddox, M.D., assistant professor of cardiology at Washington University School of Medicine in St. Louis, urge policy makers to target innovations to …

Dr. John Halamka named president of Mayo Clinic Platform | 12/4/2019

… patients and to support Mayo Clinic’s path for the future.” As the leader for innovation at Beth Israel Lahey Health, Dr. Halamka oversaw digital health relationships with industry, academia and government worldwide. As a Harvard Medical School professor, he served the George W. Bush administration, the Obama administration and governments around the world planning their health care information (IT) strategies. In his role at Beth Israel Deaconess Medical Center, Dr …

Follow Harvard Medical School:    

Reprogramming the Inner Ear to Regrow Hair Cells Shows Promise to be an Effective Target for Hearing Loss Treatments | 12/4/2019

Next Article Reprogramming the Inner Ear to Regrow Hair Cells Shows Promise to be an Effective Target for Hearing Loss Treatments Scientists identify new pathway that may enable the inner ear to be reprogrammed to grow lost hair cells, which could help develop treatments to restore hearing. 3-Dec-2019 8:05 PM EST Available for logged-in reporters only CITATIONS Hair Cells , Hearing Loss Newswise — A new discovery from a …

Anxiety, Stress, Stem Cells & Climate Change on Sharon Kleyne Talk Radio | PRWeb | 12/4/2019

… Tears® EyeMist® Reduces Effects of Pollution & Relieves Dry Eye. Sharon Kleyne, Founder of Bio Logic Aqua® Research GRANTS PASS, Ore. Air Date: 2 December 2019 Guest: Ula Jurkunas, M.D., Assistant Professor of Ophthalmology at Harvard Medical School Guest: DeWayne Cecil, Ph.D., Western Region Climate Services Director NOAA What do stress, anxiety and climate change have to do with the eyes? Everything, says Sharon Kleyne, founder and research director of Bio …

Highlights for reporters from the 2019 ASCB|EMBO Meeting | 12/4/2019

… am-4:15 pmThe Doorstep Meeting features leaders in genome instability and therapies who have studied mechanisms by which cancer cells respond. The meeting is being organized by Karlene Cimprich, Stanford University, and David Pellman, Harvard Medical School and Dana Farber Cancer Institute. 12:30-3:30 pmRoom 145AOrganizers: Daniel Fletcher, University of California, Berkeley; Matthew Good, University of Pennsylvania; and Laurent Blanchoin, Grenoble at the CEA, FranceIn vitro reconstitution of biological processes from …

New Consortium Launched in Partnership with CISCRP to Improve National Clinical Research Literacy | PRWeb | 12/4/2019

New Consortium Launched in Partnership with CISCRP to Improve National Clinical Research Literacy Share Article The Center for Information and Study on Clinical Research Participation (CISCRP) and 10 leading drug development sponsor and services companies have formed a new consortium to bring grass roots education and awareness into underserved and minority communities throughout the U.S. over a five-year period. To address the critical need to improve patient diversity in …

Roberta Sydney Elected to Tiedemann Advisors Board of Directors | Business Wire | 12/4/2019

… well-positioned for this role.” Ms. Sydney is an active, independent Board Member across the private and non-profit sectors. She serves on the boards of Plaxall Inc., Beth Israel Deaconess Medical Center of Harvard Medical School and C200. She also advises several real estate technology companies, including Rental Beast, Embue and Cobu. Ms. Sydney received a bachelor’s degree in French Language and Literature from Wellesley College, a master’s degree …

Dr. John Halamka named president of Mayo Clinic Platform. | 12/4/2019

… patients and to support Mayo Clinic’s path for the future.” As the leader for innovation at Beth Israel Lahey Health, Dr. Halamka oversaw digital health relationships with industry, academia and government worldwide. As a Harvard Medical School professor, he served the George W. Bush administration, the Obama administration and governments around the world planning their health care information (IT) strategies. In his role at Beth Israel Deaconess Medical Center, Dr …

Trump Calling Adam Schiff ‘Deranged’ Is a Projection of What the President Thinks of Himself, Says Psychiatrist | 12/4/2019

On 12/4/19 at 6:05 AM EST Share U.S. Donald Trump Msnbc Donald Trump’s description of Chair of the House Intelligence Committee Adam Schiff as a “deranged human being” is simply the president projecting onto others what is true about himself, a prominent psychiatrist has said. On the sidelines of the NATO summit in the U.K., Trump said on Tuesday that Schiff’s handling of the impeachment process showed that he “grew …

Harvard psychiatrist explains the ‘primitive’ psychological mechanism Trump uses when attacking Adam Schiff and others | 12/4/2019

… impeachment hearings has been House Intelligence Chairman Adam Schiff, who he has described as a “dog,” a “deranged human being” and a “very sick man.” And according to Dr. Lance Dodes, a well-known Harvard Medical School psychiatrist, Trump’s Schiff-related insults are a prime example of what people in the mental health field call “projection.” ADVERTISEMENT Dodes has been expressing his views on Trump’s mental health for two years …

How to protect yourself and your home this winter | 12/4/2019

Don’t use your snowblower in the dark. Do make sure kids and pets are indoors when you’re using one. And don’t stick your hand in the chute when the blower’s running, slowing down or jammed. Common sense, right? Thousands of gruesome snowblower injuries happen each year, according to the Cleveland Clinic. Most commonly, the patient is a man in his mid-40s with an injury to, or an amputation of …

Mayo Clinic hires health IT veteran John Halamka to lead digital health strategy, AI projects | FierceHealthcare | 12/4/2019

… pursued graduate work in bioengineering at the University of California, Berkeley focusing on technology issues in medicine. He completed his residency at Harbor–UCLA Medical Center in the Department of Emergency Medicine. As a Harvard Medical School professor, he served in the George W. Bush and Obama administrations, as well as governments in other countries, planning their healthcare IT strategies. The health IT veteran also is a well-known blogger …

Arkansas reports additional flu deaths | 12/4/2019

Doctors urge patients to get their flu shots now The flu season normally starts towards the end of the fall, but seasonal influenza is reportedly starting much earlier this year. Fox News’ Dr. Manny Alvarez sits down with a Harvard Medical School doctor to discuss everything you need to know about this year’s flu season. At least two more people in Arkansas have died from the flu , bringing the state’s …

Reprogramming inner ear to regrow hair cells promising target for hearing loss treatments | 12/4/2019

A new discovery from a team led by Massachusetts Eye and Ear researchers may bring scientists a step closer to developing treatments that regrow the missing cells that cause hearing loss. In a new study, published online December 4, 2019, in Nature Communications , scientists report a new strategy to induce cell division in the mature inner ear. With this pathway, they were able to reprogram the inner ear’s cells to …

Fun Test: Pick A Butterfly To Know More About Your Personality | 12/4/2019

… thereby revealing your innate personality traits. In fact, the colors you are most drawn to represent certain emotions or trigger certain senses that could define your personality. Steven Gans, assistant professor of psychiatry at Harvard Medical School points out how colors have a deep impact on our being and how they can influence our mood. Getty Images This brings us to the significance of butterflies. Butterflies are not only colorful …

The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease | BMJ | 12/3/2019

… Working Group 1 Rheumatology Unit , Massachusetts General Hospital , Boston , Massachusetts , USA 2 Maternal-Fetal Medicine , McMaster University Faculty of Health Sciences , Hamilton , Ontario , Canada 3 Gastroenterology & Hepatology , Mayo Clinic , Rochester , Minnesota , USA 4 Rheumatology , Harvard Medical School , Boston , Massachusetts , USA 5 Cancer Center , Massachusetts General Hospital , Boston , Massachusetts , USA 6 Pinnacle Inc , Montreal , Ontario , Canada 7 Department of Radiology , Kanazawa University , Kanazawa , Japan 8 Division of Rheumatology, Department of Internal …

New AI Biotech Company Zenerchi Announces Partnership with Pop Life Global | Business Wire | 12/3/2019

SALT LAKE CITY- Life extension and biomedical simulation and visualization AI company Zenerchi™ ( www.simviz.com ) and Pop Life Global ( www.pop-life.com ) have entered into an agreement for development of the consumer product line and brand extension for Zenerchi LLC in Asia. China based Pop Life will work with the developers of Zenerchi in the advancement of consumer and business applications of its physiological simulation and visualization AI platform. This new realm …

Animal rights group accuses Harvard Medical School of violating Animal Welfare Act - The Boston Globe | 12/3/2019

An animal rights group has filed a federal complaint against Harvard Medical School after learning that a monkey died of strangulation at a research facility this summer. Stop Animal Exploitation Now filed an official complaint against the school on Nov. 30 , saying it failed “to handle animals as expeditiously and carefully as possible in a manner that does not cause trauma” and did not list “any primates used in projects …

Genome | What Is Personalized Medicine? | 12/3/2019

August 3, 2014 What Is Personalized Medicine? It’s changing the world of healthcare. What you need to know about the movement fueled by genomic testing and tailored treatment. by Dawn McMullan You go to your doctor with your symptoms, and you get an evaluation, maybe have a few tests run. If you are lucky, you’re on your way to a diagnosis and a path to feeling better. How much more …

Rashi School to host parenting lecture by Brookline resident | 12/3/2019

The Rashi School, 8000 Great Meadow Road, Dedham, will host a parenting lecture from 7 to 9 p.m. Dec. 11 with Michael Rich, associate professor of pediatrics at Harvard Medical School, associate professor of social and behavioral science at the Harvard T.H. Chan School of Public Health and a practitioner of adolescent medicine at Boston Children’s Hospital. Rich, of Brookline, will address the topic of “Reclaiming Childhood from the River …

National Institutes of Health

Reprogramming the Inner Ear to Regrow Hair Cells Shows Promise to be an Effective Target for Hearing Loss Treatments | 12/4/2019

… the Eaton-Peabody Laboratories at Mass. Eye and Ear, and an Associate Professor of Otolaryngology–Head and Neck Surgery at Harvard Medical School. “These findings of renewed proliferation and hair cell generation in a fully … he added. Dr. Chen’s new study was funded by the National Institutes of Health (NIH R01DC006908), Department of Defense (DOD W81XWH1810331, Fredrick and Ines Yeatts hair cell regeneration fellowship and David-Shulsky Foundation (Z768). Patent …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Blood Disorder Foundation GNYHA Services Golden Meditech Government Scientific Source Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO … Foundation National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health National Transfusiology Center NCPC GeneTech New York Blood Center Novartis NovImmune Novo Nordisk Nxstage Medical Octapharma OMRF OrSense Ortho-Clinical Diagnostics …

Mental Health

Inside The 2019 Forbes Healthcare Summit | 12/4/2019

… through competition and innovation. She returns to the summit, two years into her tenure, to share what she’s accomplished and what’s on the horizon. PAUL FARMER Cofounder, Partners In Health; Kolokotrones University Professor, Harvard Medical School Dr. Paul Farmer has dedicated his life to strengthening health systems and improving healthcare delivery, particularly in resource-poor regions of the world. His mission: to end global health crises, from AIDS to Ebola …

Psychiatrist Brings Streamer To Tears During Confessional Stream | 12/4/2019

… current streamer who’s now working on his own online game, Everland . Over the years, he’s been fairly public about his mental health. On Twitter, he’s said that he has both depression and bipolar , and he’s … describes him as a psychiatrist whose training includes work at Harvard Medical School, McLean Hospital, and Massachusetts General Hospital. He streams discussions focused on mental health and meditation, regularly dispensing advice to his viewers and …

Medicare

Inside The 2019 Forbes Healthcare Summit | 12/4/2019

Medicare & Medicaid Services (CMS) Since joining the Trump Administration, Seema Verma has set a bold new agenda, including goals to empower patients and transform healthcare through competition and innovation. She returns to the summit, two years into her tenure, to share what she’s accomplished and what’s on the horizon. PAUL FARMER Cofounder, Partners In Health; Kolokotrones University Professor, Harvard Medical School Dr. Paul Farmer has dedicated his life to strengthening …

Lack of specialists doom rural sick patients | 12/4/2019

… of health management and policy at Saint Louis University College for Public Health and Social Justice, looked at data from Medicare patients who have chronic health problems. The paper was published in the December 2019 … in the division of health policy and insurance research at Harvard Medical School and the Harvard Pilgrim Health Care Institute, and Karen E. Joynt Maddox, M.D., assistant professor of cardiology at Washington University School of …

Food and Drug Administration

23 and Baby | Nature | 12/4/2019

… signs of disease. For this study, called the BabySeq Project, Robert Green of Brigham and Women’s Hospital, Alan Beggs of Harvard Medical School and their colleagues recruited families and randomly assigned half of them to … about the child’s sensitivity to certain drugs, although the U.S. Food and Drug Administration has recently been pressuring companies not to make such information available, because it says that it has not reviewed the tests …

CBD oil items abound, but do they in fact work? Some say yes while specialists urge care | 12/3/2019

… illustration) ‘Claims outpacing the science’ “We don’t understand yet just what it really works for,” said Dr. Peter Grinspoon, a Harvard Medical School teacher on staff at Massachusetts General Hospital. “That’s not saying it does … and products to deal with health conditions. And so the Food And Drug Administration is keeping a general public hearing the following month to assemble information linked to product safety and has now created an …

Medical Research

Global Proteomics Partnering Terms and Agreements 2014-2019 - Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication | The Wapakoneta Daily News | 12/4/2019

… Inflammation Centogene Centre For Proteomic & Genomic Research Chan Soon-Shiong Institute of Molecular Medicine Children’s Hospital of Orange County Children’s Medical Research Institute Children’s Hospital Colorado Chugai Pharmaceutical Cisbio Bioassays Codexis Core Diagnostics India COTA … Group GNS Healthcare Grace Bio-Labs Gritstone Oncology Halozyme Therapeutics Harvard Medical School Heptares Therapeutics Icahn School of Medicine at Mount Sinai Illumina Immune Design IncellDx Indiana University Indivumed Inhibikase Therapeutics Innova Biosciences Institute for …

Global Proteomics Partnering Terms and Agreements 2014-2019 - Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication | Benzinga | 12/4/2019

… Inflammation Centogene Centre For Proteomic & Genomic Research Chan Soon-Shiong Institute of Molecular Medicine Children’s Hospital of Orange County Children’s Medical Research Institute Children’s Hospital Colorado Chugai Pharmaceutical Cisbio Bioassays Codexis Core Diagnostics India COTA … Group GNS Healthcare Grace Bio-Labs Gritstone Oncology Halozyme Therapeutics Harvard Medical School Heptares Therapeutics Icahn School of Medicine at Mount Sinai Illumina Immune Design IncellDx Indiana University Indivumed Inhibikase Therapeutics Innova Biosciences Institute for …

NIH

Reprogramming the Inner Ear to Regrow Hair Cells Shows Promise to be an Effective Target for Hearing Loss Treatments | 12/4/2019

… the Eaton-Peabody Laboratories at Mass. Eye and Ear, and an Associate Professor of Otolaryngology–Head and Neck Surgery at Harvard Medical School. “These findings of renewed proliferation and hair cell generation in a fully … new study was funded by the National Institutes of Health (NIH R01DC006908), Department of Defense (DOD W81XWH1810331, Fredrick and Ines Yeatts hair cell regeneration fellowship and David-Shulsky Foundation (Z768). Patent applications based on the …

Highlights for reporters from the 2019 ASCB|EMBO Meeting | 12/4/2019

… studied mechanisms by which cancer cells respond. The meeting is being organized by Karlene Cimprich, Stanford University, and David Pellman, Harvard Medical School and Dana Farber Cancer Institute. 12:30-3:30 pmRoom 145AOrganizers: Daniel Fletcher, University of … Cellular, and Developmental Biology, National Institute of General Medical Sciences, NIH“Diversity” and related topics such as “inclusion,”“equity,” and “broadening participation” are often discussed throughout the research enterprise – from campuses to funding agencies. However …

Medicaid

Inside The 2019 Forbes Healthcare Summit | 12/4/2019

Medicaid Services (CMS) Since joining the Trump Administration, Seema Verma has set a bold new agenda, including goals to empower patients and transform healthcare through competition and innovation. She returns to the summit, two years into her tenure, to share what she’s accomplished and what’s on the horizon. PAUL FARMER Cofounder, Partners In Health; Kolokotrones University Professor, Harvard Medical School Dr. Paul Farmer has dedicated his life to strengthening health …

23 and Baby | Nature | 12/4/2019

… the country, and lawmakers from California have introduced federal legislation to cover the cost of sequencing critically ill babies through Medicaid. As of last November, Kingsmore and his colleagues had sequenced more than 1,100 babies … Robert Green of Brigham and Women’s Hospital, Alan Beggs of Harvard Medical School and their colleagues recruited families and randomly assigned half of them to have their babies’ genomes sequenced. They developed a list of …

Clinical Research

New Consortium Launched in Partnership with CISCRP to Improve National Clinical Research Literacy | PRWeb | 12/4/2019

New Consortium Launched in Partnership with CISCRP to Improve National Clinical Research Literacy Share Article The Center for Information and Study on Clinical Research Participation (CISCRP) and 10 leading drug development sponsor and services companies … and Engagement (CARE) Research Center at the Massachusetts General Hospital, Harvard Medical School. The Consortium initiative builds on CISCRP’s 18-year experience producing and hosting internationally recognized live educational events – called AWARE-for-ALL programs …

New Consortium Launched in Partnership with CISCRP to Improve National Clinical Research Literacy | Markets Insider | Business Insider | 12/4/2019

… that minority communities have a high willingness to participate in clinical trials and high self-reported general knowledge about the clinical research process. Yet, according to a recent study conducted by the Center for the … and Engagement (CARE) Research Center at the Massachusetts General Hospital, Harvard Medical School . The Consortium initiative builds on CISCRP’s 18-year experience producing and hosting internationally recognized live educational events – called AWARE-for-ALL programs …

Biotech

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Global Hematology Partnering 2014 to 2019 provides the full collection of Hematology disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Most of the deals included within the report occur when a … Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO Henry Schein Heska Hologic Homology Medicines Horiba Horizon Pharma plc …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Benzinga | 12/4/2019

… Global Hematology Partnering 2014 to 2019 provides the full collection of Hematology disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Most of the deals included within the report occur when a … Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO Henry Schein Heska Hologic Homology Medicines Horiba Horizon Pharma plc …

Medical Education

Dr. John Halamka named president of Mayo Clinic Platform | 12/4/2019

… at Beth Israel Deaconess Medical Center for more than 20 years. He also was the International Healthcare Innovation Professor at Harvard Medical School. He remains chairman of New England Healthcare Exchange Network Inc. and is … Department of Business Development; and president of Mayo Foundation for Medical Education and Research. About Mayo Clinic Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion …

For Black Women, Hair Care Is a Barrier to Exercise, Fighting Obesity | U.S. News & World Report | 12/4/2019

… medicine physicians. The study recommends incorporating this type of barrier to exercise into cultural-competency training for clinicians, including through medical education curriculums. Dr. Sophia Tolliver, an assistant professor of family medicine at the Ohio … women,” says Dr. Fatima Cody Stanford, an assistant professor at Harvard Medical School and an obesity specialist at Massachusetts General Hospital . An African American woman who’s disciplined about her fitness regimen, Cody Stanford says she …

Novartis

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Blood Disorder Foundation GNYHA Services Golden Meditech Government Scientific Source Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO … Health National Transfusiology Center NCPC GeneTech New York Blood Center Novartis NovImmune Novo Nordisk Nxstage Medical Octapharma OMRF OrSense Ortho-Clinical Diagnostics Otsuka Oxford BioMedica Palex Medical Pan American Cancer Treatment Centers PathoQuest Pathway Diagnostics …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Benzinga | 12/4/2019

… Blood Disorder Foundation GNYHA Services Golden Meditech Government Scientific Source Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO … Health National Transfusiology Center NCPC GeneTech New York Blood Center Novartis NovImmune Novo Nordisk Nxstage Medical Octapharma OMRF OrSense Ortho-Clinical Diagnostics Otsuka Oxford BioMedica Palex Medical Pan American Cancer Treatment Centers PathoQuest Pathway Diagnostics …

Merck

Inside The 2019 Forbes Healthcare Summit | 12/4/2019

… attendees will discuss the latest healthcare solutions for the brain, body and business. KENNETH C. FRAZIER Chairman & Chief Executive Officer, Merck & Co., Inc. In a special conversation with Steve Forbes, this inspiring agent of change … horizon. PAUL FARMER Cofounder, Partners In Health; Kolokotrones University Professor, Harvard Medical School Dr. Paul Farmer has dedicated his life to strengthening health systems and improving healthcare delivery, particularly in resource-poor regions of the …

New Consortium Launched in Partnership with CISCRP to Improve National Clinical Research Literacy | PRWeb | 12/4/2019

… focus energy and resources on community-based education during the next five years beginning in early 2020. Consortium members include Merck, IQVIA, Biogen, Otsuka, CSL Behring, Janssen, WCG, Boston Scientific, EMD Serono, and Pfizer. Representatives … and Engagement (CARE) Research Center at the Massachusetts General Hospital, Harvard Medical School. The Consortium initiative builds on CISCRP’s 18-year experience producing and hosting internationally recognized live educational events – called AWARE-for-ALL programs …

Pfizer

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Blood Disorder Foundation GNYHA Services Golden Meditech Government Scientific Source Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO … Centers PathoQuest Pathway Diagnostics PBM Capital Group Peking University Pfenex Pfizer Pfizer Japan Pharmacosmos PhaseBio Pharmaceuticals Pieris Portola Pharmaceuticals Premier Inc Promethera Biosciences Prophylix Pharma Protagonist Therapeutics Provepharm Qiagen Quotient Bioscience Regen BioPharma Research Center …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Benzinga | 12/4/2019

… Blood Disorder Foundation GNYHA Services Golden Meditech Government Scientific Source Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO … Centers PathoQuest Pathway Diagnostics PBM Capital Group Peking University Pfenex Pfizer Pfizer Japan Pharmacosmos PhaseBio Pharmaceuticals Pieris Portola Pharmaceuticals Premier Inc Promethera Biosciences Prophylix Pharma Protagonist Therapeutics Provepharm Qiagen Quotient Bioscience Regen BioPharma Research Center …

Bristol-Myers Squibb

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Foundation Blood Bank Of Delmarva Blood Centers of America Blood Systems Bluebird Bio BMG Pharmaceuticals Bonfils Blood Center Boryung Pharmaceutical Bristol-Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute … Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO Henry Schein Heska Hologic Homology Medicines Horiba Horizon Pharma plc …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Benzinga | 12/4/2019

… Foundation Blood Bank Of Delmarva Blood Centers of America Blood Systems Bluebird Bio BMG Pharmaceuticals Bonfils Blood Center Boryung Pharmaceutical Bristol-Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute … Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO Henry Schein Heska Hologic Homology Medicines Horiba Horizon Pharma plc …

Bristol-Myers

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Foundation Blood Bank Of Delmarva Blood Centers of America Blood Systems Bluebird Bio BMG Pharmaceuticals Bonfils Blood Center Boryung Pharmaceutical Bristol-Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute … Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO Henry Schein Heska Hologic Homology Medicines Horiba Horizon Pharma plc …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Benzinga | 12/4/2019

… Foundation Blood Bank Of Delmarva Blood Centers of America Blood Systems Bluebird Bio BMG Pharmaceuticals Bonfils Blood Center Boryung Pharmaceutical Bristol-Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute … Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO Henry Schein Heska Hologic Homology Medicines Horiba Horizon Pharma plc …

Amgen

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Advanced Biological Laboratories AffaMed Therapeutics AkaRx Akebia Therapeutics Akers Biosciences Akron Biotechnology Alchemia Alnylam Pharmaceuticals Alphamedix American society of Hematology Amgen Anthos Therapeutics Antitope Apceth Aplagon ApoPharma Aptevo Therapeutics APT Therapeutics ArcherDX Arch Therapeutics Armaghan … Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO Henry Schein Heska Hologic Homology Medicines Horiba Horizon Pharma plc …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Benzinga | 12/4/2019

… Advanced Biological Laboratories AffaMed Therapeutics AkaRx Akebia Therapeutics Akers Biosciences Akron Biotechnology Alchemia Alnylam Pharmaceuticals Alphamedix American society of Hematology Amgen Anthos Therapeutics Antitope Apceth Aplagon ApoPharma Aptevo Therapeutics APT Therapeutics ArcherDX Arch Therapeutics Armaghan … Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO Henry Schein Heska Hologic Homology Medicines Horiba Horizon Pharma plc …

Biogen

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Baylor College of Medicine Beijing Leadman Biochemistry Belgian Red Cross Bicycle Therapeutics Bill and Melinda Gates Foundation Biocept BIOCORP bioCSL Biogen BioMatrix Specialty Pharmacy Biomedical Advanced Research and Development Authority BioMedical Drug Development BioNano Genomics … Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO Henry Schein Heska Hologic Homology Medicines Horiba Horizon Pharma plc …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Benzinga | 12/4/2019

… Baylor College of Medicine Beijing Leadman Biochemistry Belgian Red Cross Bicycle Therapeutics Bill and Melinda Gates Foundation Biocept BIOCORP bioCSL Biogen BioMatrix Specialty Pharmacy Biomedical Advanced Research and Development Authority BioMedical Drug Development BioNano Genomics … Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO Henry Schein Heska Hologic Homology Medicines Horiba Horizon Pharma plc …

GlaxoSmithKline

Global Proteomics Partnering Terms and Agreements 2014-2019 - Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication | The Wapakoneta Daily News | 12/4/2019

GlaxoSmithKline Global Centers for Therapeutic Innovation Global Genomics Group GNS Healthcare Grace Bio-Labs Gritstone Oncology Halozyme Therapeutics Harvard Medical School Heptares Therapeutics Icahn School of Medicine at Mount Sinai Illumina Immune Design IncellDx Indiana University Indivumed Inhibikase Therapeutics Innova Biosciences Institute for Systems Biology Institute of Bioinformatics Integrated Diagnostics Integrated DNA Technologies Inventiva Invetech INVISTA Technologies Israeli National Authority for Technological Innovation Janssen Diagnostics Jeffrey Modell Foundation JPT Peptide …

Global Proteomics Partnering Terms and Agreements 2014-2019 - Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication | Benzinga | 12/4/2019

GlaxoSmithKline Global Centers for Therapeutic Innovation Global Genomics Group GNS Healthcare Grace Bio-Labs Gritstone Oncology Halozyme Therapeutics Harvard Medical School Heptares Therapeutics Icahn School of Medicine at Mount Sinai Illumina Immune Design IncellDx Indiana University Indivumed Inhibikase Therapeutics Innova Biosciences Institute for Systems Biology Institute of Bioinformatics Integrated Diagnostics Integrated DNA Technologies Inventiva Invetech INVISTA Technologies Israeli National Authority for Technological Innovation Janssen Diagnostics Jeffrey Modell Foundation JPT Peptide …

GE Healthcare

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

GE Healthcare Gencia Biotech Genexine Genoptix GenTegra GenVec Genzyme Global Blood Disorder Foundation GNYHA Services Golden Meditech Government Scientific Source Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO Henry Schein Heska Hologic Homology Medicines Horiba Horizon Pharma plc Immucor Immune Deficiency Foundation Incyte Inserm Inserm Transfert Institute for Genome Statistics and Bioinformatics Institute …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Benzinga | 12/4/2019

GE Healthcare Gencia Biotech Genexine Genoptix GenTegra GenVec Genzyme Global Blood Disorder Foundation GNYHA Services Golden Meditech Government Scientific Source Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO Henry Schein Heska Hologic Homology Medicines Horiba Horizon Pharma plc Immucor Immune Deficiency Foundation Incyte Inserm Inserm Transfert Institute for Genome Statistics and Bioinformatics Institute …

Medline

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Blood Disorder Foundation GNYHA Services Golden Meditech Government Scientific Source Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO … Masters Speciality Pharma Mayo Clinic Medgenics Medial Medica MedImmune Meditrade Medline Industries Menarini Merus Labs International Metabasis Therapeutics MicroHealth Miraca Life Sciences Mitsubishi Tanabe Pharma Moberg Pharma National Center for Advancing Translational Sciences (NCATS) National …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Benzinga | 12/4/2019

… Blood Disorder Foundation GNYHA Services Golden Meditech Government Scientific Source Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO … Masters Speciality Pharma Mayo Clinic Medgenics Medial Medica MedImmune Meditrade Medline Industries Menarini Merus Labs International Metabasis Therapeutics MicroHealth Miraca Life Sciences Mitsubishi Tanabe Pharma Moberg Pharma National Center for Advancing Translational Sciences (NCATS) National …

Deerfield Management

Civetta Therapeutics Announces $53 million Series A to Advance Lead Programs and Develop Proprietary Platform Targeting Propeller Proteins - Stocks News Feed | 12/4/2019

… announced a $53 million Series A financing to advance select programs and a proprietary platform focused on beta-propeller proteins. Deerfield Management established the new Company in early 2019 with Civetta scientific founders William Sellers … Professor of Medicine at the Dana-Farber Cancer Institute and Harvard Medical School, and senior advisor to the president for experimental therapeutics at the Dana-Farber Cancer Institute Eric Fischer, PhD, is an Assistant Professor …

Senior Scientist, Computational Chemistry - Cambridge, MA, , USA #jobs #Cambridge pls RT | 11/8/2019

Deerfield Management is an investment management firm committed to improving healthcare through investment, information and philanthropy. We have just launched a new company called Civetta Therapeutics located in Cambridge, MA that was founded by William Sellers (Broad Institute and Dana-Farber Cancer Institute) and Eric Fischer (Dana Farber Cancer Institute and Harvard Medical School). We are looking to engage a high-quality team of researchers to advance new medicines through …

Goldman Sachs

Tuesday, November 26, 2019 | Kaiser Health News | 11/26/2019

… Chicago-based Outcome to raise $487.5 million of equity financing and borrow $485 million, with investors that included affiliates of Goldman Sachs Group Inc, Google parent Alphabet Inc and Pritzker Group. (Stempel, 11/25) Medicaid University … Unapproved Drug New research led by Dr. Pieter Cohen of Harvard Medical School documents five supplement brands for sale in the U.S. that contain various amounts of piracetam, a drug prescribed in European countries for …

A New Capitalist: An Immigrant Story | Forbes | 6/19/2019

… about how things worked in the world. So she moved to the business world – first on the healthcare desk at Goldman Sachs and then as a private equity investor at TPG Capital – and sat at … her MBA at Harvard Business School and is now attending Harvard Medical School, where she is able now to study with the help of financial aid from the Paul and Daisy Soros Fellowship for New …

Alexandria Venture Investments

Immunitas Therapeutics Launches with $39 Million to Advance Lead Programs to Human Efficacy Studies Based on a Unique Immunology-Focused Drug Development Platform on Stocks News Feed | 11/24/2019

… A financing led by Leaps by Bayer and Novartis Venture Fund and joined by additional investors including Evotec, M Ventures, Alexandria Venture Investments, and other institutional investors. The company plans to use this funding to … the Dana-Farber Cancer Institute and Professor of Neurology at Harvard Medical School, Mario Suvà M.D., Ph.D ., an Associate Professor in the Department of Pathology at Massachusetts General Hospital and at the Broad Institute of …

Alexandria Venture

Immunitas Therapeutics Launches with $39 Million to Advance Lead Programs to Human Efficacy Studies Based on a Unique Immunology-Focused Drug Development Platform on Stocks News Feed | 11/24/2019

… A financing led by Leaps by Bayer and Novartis Venture Fund and joined by additional investors including Evotec, M Ventures, Alexandria Venture Investments, and other institutional investors. The company plans to use this funding to … the Dana-Farber Cancer Institute and Professor of Neurology at Harvard Medical School, Mario Suvà M.D., Ph.D ., an Associate Professor in the Department of Pathology at Massachusetts General Hospital and at the Broad Institute of …

New Enterprise Associates

Sanofi and Aetion launch enterprise-wide collaboration to advance regulatory submissions using real-world evidence | PR Newswire | 11/20/2019

Harvard Medical School faculty with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era. Aetion is based in New York City , and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, Amgen Ventures …

Sanofi and Aetion launch enterprise-wide collaboration to advance regulatory submissions using real-world evidence | Markets Insider | Business Insider | 11/20/2019

Harvard Medical School faculty with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era. Aetion is based in New York City , and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, Amgen Ventures …

Flare Capital Partners

Sanofi and Aetion launch enterprise-wide collaboration to advance regulatory submissions using real-world evidence | PR Newswire | 11/20/2019

Harvard Medical School faculty with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era. Aetion is based in New York City , and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, Amgen Ventures …

Sanofi and Aetion launch enterprise-wide collaboration to advance regulatory submissions using real-world evidence | Markets Insider | Business Insider | 11/20/2019

Harvard Medical School faculty with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era. Aetion is based in New York City , and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, Amgen Ventures …

McKesson Ventures

Sanofi and Aetion launch enterprise-wide collaboration to advance regulatory submissions using real-world evidence | PR Newswire | 11/20/2019

Harvard Medical School faculty with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era. Aetion is based in New York City , and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, Amgen Ventures …

Sanofi and Aetion launch enterprise-wide collaboration to advance regulatory submissions using real-world evidence | Markets Insider | Business Insider | 11/20/2019

Harvard Medical School faculty with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era. Aetion is based in New York City , and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, Amgen Ventures …

Amgen Ventures

Sanofi and Aetion launch enterprise-wide collaboration to advance regulatory submissions using real-world evidence | PR Newswire | 11/20/2019

Harvard Medical School faculty with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era. Aetion is based in New York City , and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, Amgen Ventures

Sanofi and Aetion launch enterprise-wide collaboration to advance regulatory submissions using real-world evidence | Markets Insider | Business Insider | 11/20/2019

Harvard Medical School faculty with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era. Aetion is based in New York City , and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, Amgen Ventures

Khosla Ventures

People are terrible judges of talent. Can algorithms do better? | 11/19/2019

… so carefully that she needs to block out any distractions. As a cognitive scientist turned entrepreneur who’s held fellowships with Harvard Medical School and the Massachusetts Institute of Technology, Polli possesses the kind of pedigree … The company’s primary backers are General Atlantic, Jazz Venture Partners, Khosla Ventures, Salesforce Ventures, and Workday Ventures, and it has thus far raised $56.6 million in funding . At the same time, the AI-driven hiring …

Xenotransplant Developer eGenesis Raises $100M in Series B Financing | 11/8/2019

… gene editing platform, has raised $100 million in Series B financing. The company’s co-founders include George Church, PhD, of Harvard Medical School. [eGenesis] Share eGenesis, a developer of human-compatible organs created through its … limited to, ARCH Venture Partners, Biomatics Capital, Alta Partners, and Khosla Ventures. The new financing brings eGenesis’ total capital raised to approximately $140 million, since the company garnered $38 million in Series A financing in …

General Atlantic

People are terrible judges of talent. Can algorithms do better? | 11/19/2019

… so carefully that she needs to block out any distractions. As a cognitive scientist turned entrepreneur who’s held fellowships with Harvard Medical School and the Massachusetts Institute of Technology, Polli possesses the kind of pedigree … is betting on Pymetrics, too. The company’s primary backers are General Atlantic, Jazz Venture Partners, Khosla Ventures, Salesforce Ventures, and Workday Ventures, and it has thus far raised $56.6 million in funding . At the same …

Len Blavatnik made his first billions in the country he’d left after college | Bloomberg | 5/6/2019

… Music’s Pre-Grammy Party, rubbing shoulders with pop stars Rita Ora and Lizzo. In November, he gifted $200 million to Harvard Medical School, and in June he bought London’s historic Theatre Royal Haymarket for a … science from Columbia University. He worked at Arthur Andersen and General Atlantic Partners and got an MBA from Harvard. But the opportunities for enrichment in post-Soviet Russia soon lured him back. After setting up …

Massachusetts General Hospital

Psychiatrist Brings Streamer To Tears During Confessional Stream | 12/4/2019

… Harvard Medical School, McLean Hospital, and Massachusetts General Hospital. He streams discussions focused on mental health and meditation, regularly dispensing advice to his viewers and sometimes to other streamers as well. He also notes that he does “not provide medical services or professional counseling online” and his Twitch and Discord community, Healthy Gamer, “is not a substitute for professional medical care.” Kanojia describes himself as a firm believer in both …

Reprogramming the Inner Ear to Regrow Hair Cells Shows Promise to be an Effective Target for Hearing Loss Treatments | 12/4/2019

… the Eaton-Peabody Laboratories at Mass. Eye and Ear, and an Associate Professor of Otolaryngology–Head and Neck Surgery at Harvard Medical School. “These findings of renewed proliferation and hair cell generation in a fully … ZhengminWang, Huawei Li of Shanghai TK and Konrad Hochedlinger at Massachusetts General Hospital were also co-authors. About Massachusetts Eye and Ear Massachusetts Eye and Ear, founded in 1824, is an international center for treatment …

Beth Israel Deaconess Medical Center

Dr. John Halamka named president of Mayo Clinic Platform | 12/4/2019

Beth Israel Deaconess Medical Center for more than 20 years. He also was the International Healthcare Innovation Professor at Harvard Medical School. He remains chairman of New England Healthcare Exchange Network Inc. and is a practicing emergency medicine physician. John Halamka, M.D. “Dr. Halamka has a proven track record of success in innovation and value creation,” says Gianrico Farrugia, M.D. , president and CEO, Mayo Clinic. “His extensive experience and network …

Roberta Sydney Elected to Tiedemann Advisors Board of Directors | Business Wire | 12/4/2019

Beth Israel Deaconess Medical Center of Harvard Medical School and C200. She also advises several real estate technology companies, including Rental Beast, Embue and Cobu. Ms. Sydney received a bachelor’s degree in French Language and Literature from Wellesley College, a master’s degree in Real Estate Development from MIT and an M.B.A. from Harvard University. “I’m looking forward to joining Tiedemann’s dynamic leadership board to help challenge and govern the organization …

Mayo Clinic

Dr. John Halamka named president of Mayo Clinic Platform | 12/4/2019

Dr. John Halamka named president of Mayo Clinic Platform December 3, 2019 ROCHESTER, Minn. — John Halamka, M.D., has been named president of Mayo Clinic Platform. The platform will elevate Mayo Clinic to a global leadership … years. He also was the International Healthcare Innovation Professor at Harvard Medical School. He remains chairman of New England Healthcare Exchange Network Inc. and is a practicing emergency medicine physician. John Halamka, M.D. “Dr. Halamka …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Blood Disorder Foundation GNYHA Services Golden Meditech Government Scientific Source Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO … Mallinckrodt Pharmaceuticals Massachusetts Institute of Technology Masterlab Masters Speciality Pharma Mayo Clinic Medgenics Medial Medica MedImmune Meditrade Medline Industries Menarini Merus Labs International Metabasis Therapeutics MicroHealth Miraca Life Sciences Mitsubishi Tanabe Pharma Moberg Pharma National …

McLean Hospital

Psychiatrist Brings Streamer To Tears During Confessional Stream | 12/4/2019

… Harvard Medical School, McLean Hospital, and Massachusetts General Hospital. He streams discussions focused on mental health and meditation, regularly dispensing advice to his viewers and sometimes to other streamers as well. He also notes that he does “not provide medical services or professional counseling online” and his Twitch and Discord community, Healthy Gamer, “is not a substitute for professional medical care.” Kanojia describes himself as a firm believer in both …

Hope in Eating Disorder Treatment: How Treating Co-Occurring Disorders Helps Patients With Recovery | 12/3/2019

… 61(3):348-58.PMID: 16815322. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1892232/ About the Sponsor: The Klarman Eating Disorders Center (KEDC) at McLean Hospital provides state-of-the-art treatment for young women ages 16 to 26 … the Author: Esther Dechant, MD, received her medical degree from Harvard Medical School. She completed the residency program in psychiatry at Cambridge Hospital and a fellowship in child and adolescent psychiatry at Massachusetts General Hospital …

Cleveland Clinic

How to protect yourself and your home this winter | 12/4/2019

… blower’s running, slowing down or jammed. Common sense, right? Thousands of gruesome snowblower injuries happen each year, according to the Cleveland Clinic. Most commonly, the patient is a man in his mid-40s with an … men, die of heart attacks while shoveling snow, according to Harvard Medical School. The deeper the snow, the more heart attacks occur. Winter falls can be trouble, too. About a million people are injured annually …

Partners HealthCare

Reprogramming the Inner Ear to Regrow Hair Cells Shows Promise to be an Effective Target for Hearing Loss Treatments | 12/4/2019

… the Eaton-Peabody Laboratories at Mass. Eye and Ear, and an Associate Professor of Otolaryngology–Head and Neck Surgery at Harvard Medical School. “These findings of renewed proliferation and hair cell generation in a fully … a teaching hospital of Harvard Medical School. A member of Partners HealthCare, Mass. Eye and Ear specializes in ophthalmology (eye care) and otolaryngology–head and neck surgery (ear, nose and throat care). Mass. Eye and …

Bioinformatics/Data Scientist | Nature | 12/4/2019

… on January 31, 2020 Position in Bioinformatics/Data Science Bayer/Partners Pulmonary Drug Discovery Laboratory at Brigham and Womens Hospital Partners HealthCare is looking for an exceptional Bioinformatician/Data Scientist to join the Pulmonary Drug … pipelines for data mining. Brigham and Womens Hospital is a Harvard Medical School affiliated institution, with over 1000 principal investigators. The Channing Division of Network Medicine is a research division within the Department of Medicine …

Memorial Sloan Kettering Cancer Center

Global Proteomics Partnering Terms and Agreements 2014-2019 - Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication | The Wapakoneta Daily News | 12/4/2019

… Gladstone Institutes GlaxoSmithKline Global Centers for Therapeutic Innovation Global Genomics Group GNS Healthcare Grace Bio-Labs Gritstone Oncology Halozyme Therapeutics Harvard Medical School Heptares Therapeutics Icahn School of Medicine at Mount Sinai Illumina Immune Design … Anderson Cancer Center Medgenics Medical University of South Carolina MedImmune Memorial Sloan Kettering Cancer Center Merck and Co Metabolon Moderna Therapeutics Mologic MRM Proteomics Munich Technical University NanoString Technologies NantBioScience NantHealth National Heart Lung and …

Global Proteomics Partnering Terms and Agreements 2014-2019 - Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication | Benzinga | 12/4/2019

… Gladstone Institutes GlaxoSmithKline Global Centers for Therapeutic Innovation Global Genomics Group GNS Healthcare Grace Bio-Labs Gritstone Oncology Halozyme Therapeutics Harvard Medical School Heptares Therapeutics Icahn School of Medicine at Mount Sinai Illumina Immune Design … Anderson Cancer Center Medgenics Medical University of South Carolina MedImmune Memorial Sloan Kettering Cancer Center Merck and Co Metabolon Moderna Therapeutics Mologic MRM Proteomics Munich Technical University NanoString Technologies NantBioScience NantHealth National Heart Lung and …

Lahey Health

Dr. John Halamka named president of Mayo Clinic Platform | 12/4/2019

Lahey Health in Massachusetts. Previously, he was chief information officer at Beth Israel Deaconess Medical Center for more than 20 years. He also was the International Healthcare Innovation Professor at Harvard Medical School. He remains chairman of New England Healthcare Exchange Network Inc. and is a practicing emergency medicine physician. John Halamka, M.D. “Dr. Halamka has a proven track record of success in innovation and value creation,” says Gianrico Farrugia …

Young Americans are dying at high rates and MGH may spend $100M to change its name | 12/1/2019

… choice overly framed by recent local competition and ultimately limiting? Two of Partners local rivals merged to form Beth Israel Lahey Health, this feels like a reaction. There’s a logical limit to how many great … all, Harvard? MGH has a historically highly integrated connection to Harvard Medical School. It is a natural differentiation to draw against NY Presbyterian or Mayo Clinic. However, locally Beth Israel, Dana Farber and Boston Children’s …

Ascension

Mayo Clinic hires health IT veteran John Halamka to lead digital health strategy, AI projects | FierceHealthcare | 12/4/2019

… at Beth Israel Deaconess Medical Center for more than 20 years. He also was an International Healthcare Innovation Professor at Harvard Medical School. He remains chairman of New England Healthcare Exchange Network Inc. and is … healthcare-tech partnerships. A massive data project between Google and Ascension sparked controversy over concerns about the lack of transparency. The announced deal enables the health system to move detailed health information on more than …

How William Monroe Trotter Mobilized Black Americans Across Class Lines | 11/26/2019

… only contribution to Crumpacker’s fight came from John Fitzgerald—the Democratic son of Irish Catholic immigrants who dropped out of Harvard Medical School to support his impoverished family—proved the ignorance of blind allegiance to … windows under which his father spoke following Benjamin Butler’s triumphant ascension to the state house, Monroe Trotter made enforcement of Federal civil rights a populist movement, led and orchestrated by the masses of “genteel poor …

Boston Children's Hospital

Investigating the human intestinal mucus barrier up-close and personal | 12/3/2019

… medicine where it can be possible to study how mucus functions or dysfunctions in a particular patient, and to tailor therapy accordingly.” Ingber is also the Judah Folkman Professor of Vascular Biology at Harvard Medical School and the Vascular Biology Program at Boston Children’s Hospital, as well as Professor of Bioengineering at Harvard’s John A. Paulson School of Engineering and Applied Sciences. His team is part of a multi-institutional …

Harvard Pilgrim Health Care

Lack of specialists doom rural sick patients | 12/4/2019

Harvard Medical School and the Harvard Pilgrim Health Care Institute, and Karen E. Joynt Maddox, M.D., assistant professor of cardiology at Washington University School of Medicine in St. Louis, urge policy makers to target innovations to bring more specialist care to rural areas. Some of the strategies they suggest are: Expanding telemedicine in key areas, such as cardiology, to provide routine specialty care visits through technologies such as video conferencing …

UnitedHealthcare

Anxiety-fighting foods that may help bring calm, balance | 11/22/2019

… are key to stabilizing mood and brain function, are also found in the lining of the gut. According to a Harvard Medical School health blog , research is examining the potential of probiotics for treating both … and brain chemistry and help ease the burden of anxiety. UnitedHealthcare is dedicated to helping people live healthier lives and making the health system work better for everyone. UnitedHealthcare offers the full spectrum of health …

Study Shows I-SNP in Skilled Nursing Nets Better Outcomes at Lower Costs [Sponsored] | 11/6/2019

Harvard Medical School researchers that demonstrated the model not only delivers improved outcomes for patients, but does so at a much lower cost. The study, published in the American Journal of Managed Care, 1 included members of UnitedHealthcare’s I-SNP, with care delivered by their partner, Optum ® . Through an on-site clinical model of care, skilled nursing providers showed vastly lower rates of emergency department (ED) use, inpatient care and …

Aetna

Haven partners with traditional payers in plans offered to Amazon, JPM workers | 11/9/2019

… Wisconsin, and JPM is offering the plans in Ohio and Arizona. The JPM-Haven plans, run by payers Cigna and Aetna, don’t require employees to pay deductibles and do offer financial rewards for fulfilling certain … our employees,” an Amazon spokesperson told Healthcare Dive. Helmed by Harvard Medical School professor and New Yorker author Atul Gawande, Haven includes a powerhouse team of healthcare execs, including former UnitedHealth and Comcast executive Jack …

ORHub, Inc. Announced the Appointment of Dr. Choll Kim to their Advisory Board | Medical Device News Magazine | 11/9/2019

… of-the-art minimally invasive procedure that effectively treats herniated disks, radiculopathy and sciatica. Dr. Kim graduated cum laude from Harvard Medical School and completed his fellowship training in complex spine surgery at the Mayo … Board November 7, 2019 Germain has held leadership positions with Aetna, the global health team at the Bill and Melinda Gates Foundation, and one of the largest owner/operators of senior living communities in the …

Cigna

Haven partners with traditional payers in plans offered to Amazon, JPM workers | 11/9/2019

… Utah and Wisconsin, and JPM is offering the plans in Ohio and Arizona. The JPM-Haven plans, run by payers Cigna and Aetna, don’t require employees to pay deductibles and do offer financial rewards for … our employees,” an Amazon spokesperson told Healthcare Dive. Helmed by Harvard Medical School professor and New Yorker author Atul Gawande, Haven includes a powerhouse team of healthcare execs, including former UnitedHealth and Comcast executive Jack …

Insulin costs out of reach for some in U.S. | 11/8/2019

… to ensure they can live day to day,” said commentary co-author Dr. Aaron Kesselheim, a professor of medicine at Harvard Medical School. The current costs would no doubt disappoint Canadian scientist Banting. In the … government manufacturing facility to provide lower-cost insulin,” Kesselheim said. Cigna, a large private insurer, has limited monthly copayments for insulin to $25. Holly Campbell, a spokesperson for PhRMA, a pharmaceutical manufacturer trade association, said …

CareCentrix

CareCentrix Releases New Series of #CareTalk Podcasts and Videos Shot Live at HLTH | PR Newswire | 11/7/2019

HARTFORD, Conn. Today, CareCentrix , the leading provider of home-based, post-acute care solutions, released new episodes of their popular video and podcast series CareTalk , that were shot live at HLTH, the industry’s largest health … of Boston Children’s Hospital and Professor of Biomedical Informatics at Harvard Medical School , talked about common barriers to care, specifically patient transportation. Brownstein’s company, Circulation, provides on-demand transportation for patients without access to rides …

CareCentrix Releases New Series of #CareTalk Podcasts and Videos Shot Live at HLTH | Benzinga | 11/7/2019

HARTFORD, Conn. , Nov. 7, 2019 /PRNewswire/ – Today, CareCentrix , the leading provider of home-based, post-acute care solutions, released new episodes of their popular video and podcast series CareTalk , that were shot live at HLTH … of Boston Children’s Hospital and Professor of Biomedical Informatics at Harvard Medical School , talked about common barriers to care, specifically patient transportation. Brownstein’s company, Circulation, provides on-demand transportation for patients without access to rides …

The Health Plan

New UnitedHealthcare Benefit for Low Back Pain Helps Reduce Invasive Procedures and Address the Opioid Epidemic | Business & Finance | heraldchronicle.com | Business Wire | 10/29/2019

… fullarticle/2603228/noninvasive-treatments-acute-subacute-chronic-low-back-pain-clinical-practice . April 4, 2017. 6 Cleveland Clinic. Chronic Back Pain. https://my.clevelandclinic.org/health/diseases/16869-chronic-back-pain . Accessed July 2019. 7 Harvard Medical School, https://www.health.harvard.edu/pain/when-is-back-surgery-the-right-choice.add , 2014 View source version on businesswire.com : https://www.businesswire.com/news/home/20191029005055/en/ CONTACT: Will Shanley …

First Digital Pill Approved to Worries About Biomedical ‘Big Brother’ | MSN | 11/14/2017

the health plan division at the University of Pittsburgh Medical Center. Ameet Sarpatwari, an instructor in medicine at Harvard Medical School, said the digital pill “has the potential to improve public health,” especially for patients who want to take their medication but forget. But, he added, “if used improperly, it could foster more mistrust instead of trust.” Patients who agree to take the digital medication, a version of the antipsychotic …

Humana

Insurers test new way to cut maternity care costs: Bundling - MedCity News | 9/30/2019

… insurer said it hopes to expand to as many as 20 practices by the end of the year. Cigna and Humana are also piloting bundled maternity care programs. A few Medicaid programs, including those in … an assistant professor of obstetrics, gynecology and reproductive biology at Harvard Medical School. The pivot in payments is being made as the quality of maternity care in the United States comes under renewed scrutiny. An …

Blue Cross Blue Shield Of Massachusetts

Bristol-Myers Squibb Board Announces Election of Three New Directors | Business Wire | 9/12/2019

… University and Thomas Jefferson University Hospitals. A magna cum laude graduate of Princeton, Dr. Haller received her M.D. degree from Harvard Medical School. She served as the first female Chief Resident at the Wilmer Eye … client work. She is currently Chair of the Board of Blue Cross Blue Shield of Massachusetts and serves on the Board of DaVita, Inc. Previously, Ms. Yale served on the boards of Kindred Healthcare, Inc …

Mark Friedberg Joins Blue Cross Blue Shield Of Massachusetts Leadership Team | PR Newswire | 8/7/2019

BOSTON , Aug. 7, 2019 /PRNewswire/ – Blue Cross Blue Shield of Massachusetts (“Blue Cross”) announced today that Mark Friedberg , M.D., has joined its leadership team as senior vice president of performance measurement and improvement. Friedberg is … of medicine, part-time, at Brigham and Women’s Hospital and Harvard Medical School . Mark Friedberg named Senior Vice President of Performance Measurement and Improvement at Blue Cross Blue Shield of Massachusetts “Mark brings a strong …

Healthspan

How to Live Past 100 | Yahoo News | 9/11/2019

… How to Live Past 100 Jackie Cooperman Reblog David Sinclair, codirector of the Center for the Biology of Aging at Harvard Medical School, is optimistic. If we increase the quality of information our genes are … will be offset by huge savings in healthcare. We’re increasing healthspan, not just lifespan. That’s tens of trillions of dollars globally per decade that we can put to education and saving the environment. Population growth …

Joe Kvedar, MD Elected Next President of American Telemedicine Association | HIT Consultant | 7/25/2019

… President. Dr. Kvedar Background Dr. Kvedar is Vice President of Connected Health at Partners HealthCare , and Professor of Dermatology at Harvard Medical School. Dr. Kvedar previously served as President of ATA from 2004-2005, and was … subject: The New Mobile Age: How Technology Will Extend the Healthspan and Optimize the Lifespan (2017) and The Internet of Healthy Things (2015), and more than 1,000 publications. Beating The Drum on Telehealth Adoption “ATA …

Molina Healthcare

J. Mario Molina Named Founding Dean of the KGI School of Medicine | Business Wire | 8/27/2019

… the founding dean of the KGI School of Medicine. Molina served for 20 years as the Chief Executive Officer of Molina Healthcare, a Fortune 500 company founded by his father in 1980 to provide healthcare … Hopkins Medicine and served on the Visiting Committee for the Harvard Medical School. He is also a member of the Founder’s Council of the United States of Care. Medical education programs leading to the MD …

Donald Trump

Trump Calling Adam Schiff ‘Deranged’ Is a Projection of What the President Thinks of Himself, Says Psychiatrist | 12/4/2019

On 12/4/19 at 6:05 AM EST Share U.S. Donald Trump Msnbc Donald Trump’s description of Chair of the House Intelligence Committee Adam Schiff as a “deranged human being” is simply the president projecting onto others … Insider Says Read more The former assistant clinical professor of Harvard Medical School, Lance Dodes, who first sounded the alarm about the president’s mental state two years ago, said Trump could just as easily have …

Harvard psychiatrist explains the ‘primitive’ psychological mechanism Trump uses when attacking Adam Schiff and others | 12/4/2019

Tweet Whether they’re Democrats or Never Trump conservatives, President Donald Trump often has an insulting name for his political opponents. One of Trump’s favorite targets during the House impeachment hearings has been House Intelligence Chairman Adam Schiff, who he has described as a “dog,” a “deranged human being” and a “very sick man.” And according to Dr. Lance Dodes, a well-known Harvard Medical School psychiatrist, Trump’s Schiff-related insults …

John Halamka

Dr. John Halamka named president of Mayo Clinic Platform | 12/4/2019

Dr. John Halamka named president of Mayo Clinic Platform December 3, 2019 ROCHESTER, Minn. — John Halamka, M.D., has been named president of Mayo Clinic Platform. The platform will elevate Mayo Clinic to a global leadership … years. He also was the International Healthcare Innovation Professor at Harvard Medical School. He remains chairman of New England Healthcare Exchange Network Inc. and is a practicing emergency medicine physician. John Halamka, M.D. “Dr. Halamka …

Dr. John Halamka named president of Mayo Clinic Platform. | 12/4/2019

Dr. John Halamka named president of Mayo Clinic Platform. Posted on by Alex ROCHESTER, Minn. — John Halamka, M.D., has been named president of Mayo Clinic Platform. The platform will elevate Mayo Clinic to a global … years. He also was the International Healthcare Innovation Professor at Harvard Medical School. He remains chairman of New England Healthcare Exchange Network Inc. and is a practicing emergency medicine physician. “Dr. Halamka has a proven …

Melinda Gates

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Baxalta Baxter International Bayer Bayer Healthcare Baylor College of Medicine Beijing Leadman Biochemistry Belgian Red Cross Bicycle Therapeutics Bill and Melinda Gates Foundation Biocept BIOCORP bioCSL Biogen BioMatrix Specialty Pharmacy Biomedical Advanced Research and Development … Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO Henry Schein Heska Hologic Homology Medicines Horiba Horizon Pharma plc …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Benzinga | 12/4/2019

… Baxalta Baxter International Bayer Bayer Healthcare Baylor College of Medicine Beijing Leadman Biochemistry Belgian Red Cross Bicycle Therapeutics Bill and Melinda Gates Foundation Biocept BIOCORP bioCSL Biogen BioMatrix Specialty Pharmacy Biomedical Advanced Research and Development … Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO Henry Schein Heska Hologic Homology Medicines Horiba Horizon Pharma plc …

Paul Farmer

Inside The 2019 Forbes Healthcare Summit | 12/4/2019

… from more than 40 speakers including Stefano Pessina, CEO of Walgreens Boots Alliance, Judith Faulkner , CEO of EPIC Systems, and Paul Farmer , cofounder of Partners In Health. Representing more than 160 companies impacting the healthcare … horizon. PAUL FARMER Cofounder, Partners In Health; Kolokotrones University Professor, Harvard Medical School Dr. Paul Farmer has dedicated his life to strengthening health systems and improving healthcare delivery, particularly in resource-poor regions of the …

Christian Testament text for 1st Advent 1 December 2019 | 11/30/2019

Paul Farmer says Yes and steps out to reveal God’s presence in the world. “He works about two months a year in Boston, MA where he heads the Infectious Disease program at Harvard Medical School but the rest of the year he spends most of his time in Haiti, a poverty ridden country with no affordable health care, treating the “disposable people” of the world. Why? His faith compels him …

George W. Bush

Dr. John Halamka named president of Mayo Clinic Platform | 12/4/2019

… at Beth Israel Deaconess Medical Center for more than 20 years. He also was the International Healthcare Innovation Professor at Harvard Medical School. He remains chairman of New England Healthcare Exchange Network Inc. and is … worldwide. As a Harvard Medical School professor, he served the George W. Bush administration, the Obama administration and governments around the world planning their health care information (IT) strategies. In his role at Beth Israel …

Dr. John Halamka named president of Mayo Clinic Platform. | 12/4/2019

… at Beth Israel Deaconess Medical Center for more than 20 years. He also was the International Healthcare Innovation Professor at Harvard Medical School. He remains chairman of New England Healthcare Exchange Network Inc. and is … worldwide. As a Harvard Medical School professor, he served the George W. Bush administration, the Obama administration and governments around the world planning their health care information (IT) strategies. In his role at Beth Israel …

Adam Schiff

Quod erat demonstrandum | 12/4/2019

… the video clip below, Donald J. Trump, 45th President of the United States, should be removed from office. Trump on Adam Schiff: “I think he’s a maniac. I think Adam Schiff is a deranged human … psychiatrist Lance Dodes, a former assistant professor of psychiatry at Harvard Medical School, to assess Trump’s mental/emotional state in light of those comments. Yes, it’s projection, says Dodes. Trump “tells other people that they …

Comment on Quod erat demonstrandum by Imhotep | 12/4/2019

… the video clip below, Donald J. Trump, 45th President of the United States, should be removed from office. Trump on Adam Schiff: “I think he’s a maniac. I think Adam Schiff is a deranged human … psychiatrist Lance Dodes, a former assistant professor of psychiatry at Harvard Medical School, to assess Trump’s mental/emotional state in light of those comments. Yes, it’s projection, says Dodes. Trump “tells other people that they …

George Church

Why the paper on the CRISPR babies stayed secret for so long - MIT Technology Review | 12/3/2019

George Church of Harvard Medical School. That’s about three times as many as usual. The review hinged on both scientific and ethical issues. On paper, He had taken elaborate steps to inform the couples in the trial about what was going on, and let them choose whether to participate. But there were inexplicable irregularities, too. For example, Church says it’s not clear whether the twins were conceived and born at …

AAV Optimization on the Fast-Track Hopes to Advance Gene Therapies | 12/3/2019

… for future gene therapies,” noted Eric Kelsic, PhD, CEO of Dyno Therapeutics—a company spun out of the lab of George Church, PhD, to apply these methods to enhancing AAV vectors. “Past approaches such as … Wyss Institute’s Synthetic Biology platform and professor of genetics at Harvard Medical School. Furthermore, Church noted, they did it with efficiencies of generating viable capsids that far exceed those of AAV created by random mutagenesis …

Tej Kohli

Investor Tej Kohli Expands ‘Venture Philanthropy’ Into 3d-printed Bionic Arms | 12/3/2019

The Tej Kohli Foundation is funding 3D-printed bionic arms for 10 British children from Bristol-based robotics pioneer Open Bionics. Open Bionics is building and developing the next generation of low-cost bionic limbs … Mass Eye and Ear in Boston, a teaching hospital of Harvard Medical School, to support the development of new technologies to cure blindness. Through its ‘Impact Initiatives’ the Tej Kohli Foundation also makes direct interventions …

Michael Rich

Rashi School to host parenting lecture by Brookline resident | 12/3/2019

The Rashi School, 8000 Great Meadow Road, Dedham, will host a parenting lecture from 7 to 9 p.m. Dec. 11 with Michael Rich, associate professor of pediatrics at Harvard Medical School, associate professor of social and behavioral science at the Harvard T.H. Chan School of Public Health and a practitioner of adolescent medicine at Boston Children’s Hospital. Rich, of Brookline, will address the topic of “Reclaiming Childhood from the River …

Why the Idea of Screen Time Is an Obsolete Concept | 12/1/2019

… Michael Rich, Director of the Center on Media and Child Health at Boston Children’s Hospital/Harvard Medical School—summarises it perfectly: “Screen time has become an obsolete concept in an era where we are surrounded by screens and move seamlessly between the digital and the physical to use them in virtually all human endeavors—learning, interacting, creating, having fun. It is how we choose to use screens and to pursue …

Bill Clinton

Is the Democratic Party the Real Cult? | 12/3/2019

… the politically correct Democrats in pink pussy hats who are being brainwashed. Robert Jay Lifton, a psychiatrist who taught at Harvard Medical School, wrote a paper titled “Cult Formation” in the early 1980s where he … and the ruling coterie.” We don’t have to talk about Bill Clinton or Jeffrey Epstein here, although those are certainly disturbing instances of alleged sexual exploitation, but what I am thinking about with regards to …

November 2019 Connections | 11/20/2019

Harvard Medical School while in town for two different conferences. “We made the connection when we all noticed Rewan’s Coke Scholar backpack!” Sara said. Megan Rosenberger (2013) ran into Nasir Uddin (2006) at the Clinton Foundation Alumni Summit in New York, hosted by President Bill Clinton and Chelsea Clinton. Andrew Barnhill (2006) and Jenn Shepherd (1989) had breakfast with Carolyn Norton (CCSF, middle) on a recent trip to Wilmington, North …